跳至主要内容
临床试验/ISRCTN88261002
ISRCTN88261002已完成3 期

A multi-centre randomised placebo-controlled trial of prophylactic enteral lactoferrin supplementation to prevent late-onset invasive infection in very preterm infants

niversity of Oxford (UK)0 个研究点目标入组 2,200 人开始时间: 2013年6月13日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
2,200

研究概览

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Infants will be eligible to participate if:
  • 1. Gestational age at birth is less than 32 weeks
  • 2. Less than 72 hours old
  • 3. Written informed parental consent is obtained
  • If infants are receiving antibiotic treatment for suspected or confirmed
  • Infection, they are still eligible for recruitment.

排除标准

  • 1. Infants with severe congenital anomalies
  • 2. Anticipated enteral fasting of more than 14 days
  • 3. Infants who, in the opinion of the treating clinician, have no realistic prospect of survival

研究者

发起方
niversity of Oxford (UK)

相似试验